Cited by 168Muscle Physiology and DisordersChronic Obstructive Pulmonary Disease (COPD) ResearchNutrition and Health in Aging

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD

Open access

Remels, A. H., Schrauwen, P., Broekhuizen, R., Willems, J., Kersten, S., Gosker, H. R., Schols, A. M.·2007·European Respiratory Journal

DOI 10.1183/09031936.00144106

Open this paper in CoChat — free account Open PDF

Abstract

Chronic obstructive pulmonary disease (COPD) is a multiorgan systemic disease. The systemic features are skeletal muscle weakness and cachexia, the latter being associated with systemic inflammation. The exact mechanisms underlying skeletal muscle dysfunction in COPD remain obscure. Recent evidence suggests involvement of the peroxisome proliferator-activated receptors (PPARs) and PPAR-γ coactivator (PGC)-1α in regulation of skeletal muscle morphology and metabolism, and mitochondrial transcription factor A (TFAM) has been implicated in the process of mitochondrial biogenesis. The aim of the present exploratory study was, therefore, to compare these factors in the skeletal muscle of nine healthy control subjects and 14 COPD patients stratified by cachexia. PPAR-γ, PPAR-δ and TFAM were measured at the mRNA and protein level by real-time quantitative PCR and Western blotting, respectively. PPAR-α and PGC-1α were meansured at the mRNA level. PPAR-δ and TFAM protein content, as well as PGC-1α mRNA levels, were decreased in the skeletal muscle of COPD patients compared with healthy controls. The cachectic COPD subgroup was further characterised by decreased PPAR-α mRNA expression and decreased TFAM protein and mRNA levels compared with noncachectic COPD patients. In addition, PPAR-α mRNA levels in skeletal muscle correlated negatively with inflammatory markers in plasma. Therefore, a disturbed expression of these regulatory factors may well underlie the disturbed skeletal muscle functioning in chronic obstructive pulmonary disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1183/09031936.00144106

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546
Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α (PGC-1α): Transcriptional Coactivator and Metabolic Regulator
Puigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
Regulation of Muscle Fiber Type and Running Endurance by PPARδ
Wang, Y.-X., Zhang, C.-L., Yu, R. T., Cho, H. K., Nelson, M. C., Bayuga-Ocampo, C. R., Ham, J., Kang, H., & Evans, R. M. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020294 · Cited by 1,089
Emerging roles of PPARS in inflammation and immunity
Daynes, R. A., & Jones, D. C. (2002) · Nature reviews. Immunology · doi:10.1038/nri912 · Cited by 926
Midthigh Muscle Cross-Sectional Area Is a Better Predictor of Mortality than Body Mass Index in Patients with Chronic Obstructive Pulmonary Disease
Marquis, K., Debigaré, R., Lacasse, Y., Leblanc, P., Jobin, J., Carrier, G., & Maltais, F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107031 · Cited by 840
Invited Review: Contractile activity-induced mitochondrial biogenesis in skeletal muscle
Hood, D. A. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.90.3.1137 · Cited by 692
Statistical guidelines for contributors to medical journals.
Altman, D. G., Gore, S. M., Gardner, M. J., & Pocock, S. (1983) · BMJ · doi:10.1136/bmj.286.6376.1489 · Cited by 662
Peroxisome proliferator‐activated receptor δ controls muscle development and oxydative capability
Luquet, S., Lopez‐Soriano, J., Holst, D., Fredenrich, A., Melki, J., Rassoulzadegan, M., & Grimaldi, P. A. (2003) · The FASEB Journal · doi:10.1096/fj.03-0269fje · Cited by 509
Tumor Necrosis Factor-Alpha Levels and Weight Loss in Chronic Obstructive Pulmonary Disease
Di Francia, M., Barbier, D., Mège, J. L., & OREHEK, J. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.5.7952575 · Cited by 480
Peroxisome Proliferator-activated Receptor-γ Co-activator 1α-mediated Metabolic Remodeling of Skeletal Myocytes Mimics Exercise Training and Reverses Lipid-induced Mitochondrial Inefficiency
Koves, T. R., Li, P., An, J., Akimoto, T., Slentz, D., Ilkayeva, O., Dohm, G. L., Yan, Z., Newgard, C. B., & Muoio, D. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507621200 · Cited by 464

Show all 35 references

Research works printed but not linked: 1

10.1210/me.10.11.1457 · DOI

Sorted by citations

Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,863
An Official American Thoracic Society/European Respiratory Society Statement: Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease
Maltais, F., Decramer, M., Casaburi, R. H., Barreiro, E., Burelle, Y., Debigaré, R., Dekhuijzen, P. N. R., Franssen, F. M. E., Gayan‐Ramirez, G., Gea, J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0373st · Cited by 1,165
Self-citation
Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases
Grazioli, S., & Pugin, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00832 · Cited by 429
Mitochondria in lung disease
Cloonan, S. M., & Choi, A. M. K. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81113 · Cited by 322
Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease
Hussain, S., Cheol, K., & Mofarrahi, M. (2008) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s4480 · Cited by 224
Regulation of Skeletal Muscle Physiology and Metabolism by Peroxisome Proliferator-Activated Receptor δ
Ehrenborg, E., & Krook, A. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001560 · Cited by 222
The mechanisms of cachexia underlying muscle dysfunction in COPD
Remels, A. H. V., Gosker, H. R., LANGEN, R. C. J., & Schols, A. M. W. J. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00790.2012 · Cited by 181
Self-citation
A randomized clinical trial investigating the efficacy of targeted nutrition as adjunct to exercise training in COPD
van de Bool, C., Rutten, E. P. A., van Helvoort, A., Franssen, F. M. E., Wouters, E. F. �., & Schols, A. M. W. J. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12219 · Cited by 145
Self-citation
Muscle function in COPD: a complex interplay
Man, W. D., Donaldson, G. C., Maddocks, M. M., Martolini, & Polkey, M. I. (2012) · International Journal of COPD · doi:10.2147/copd.s28247 · Cited by 150
Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study
Abdellaoui, A., Prefaut, C., Gouzi, F., Couillard, A., Coisy‐Quivy, M., Hugon, G., Molinari, N., Lafontaine, T., Jonquet, O., Laoudj‐Chenivesse, D., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00167110 · Cited by 142
TNF‐α‐mediated reduction in PGC‐1α may impair skeletal muscle function after cigarette smoke exposure
Tang, K., Wagner, P. D., & Breen, E. C. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.21955 · Cited by 125
“In the experiments presented in the current study, mice exposed to just 16 weeks of cigarette smoke reproduced many of the muscle abnormalities seen in humans (Jobin et al., 1998; Maltais et al., 1998; Whittom et al., 1998; Remels et al., 2007; Gosker et al., 2009).”
Background
TNF-α impairs regulation of muscle oxidative phenotype: implications for cachexia?
Remels, A. H. V., Gosker, H. R., Schrauwen, P., Hommelberg, P. P. H., Sliwinski, P., Polkey, M., Galdiz, J., Wouters, E. F. M., Langen, R. C. J., & Schols, A. M. W. J. (2010) · The FASEB Journal · doi:10.1096/fj.09-150714 · Cited by 122
Self-citation
Loss of quadriceps muscle oxidative phenotype and decreased endurance in patients with mild-to-moderate COPD
van den Borst, B., Slot, I. G. M., Hellwig, V. A. C. V., Vosse, B. A. H., KELDERS, M. C. J. M., Barreiro, E., Schols, A. M. W. J., & Gosker, H. R. (2012) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00508.2012 · Cited by 124
Self-citation
Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease
Belvisi, M. G., & Mitchell, J. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00373.x · Cited by 119
Emerging Pharmacotherapies for COPD
Barnes, P. J. (2008) · CHEST Journal · doi:10.1378/chest.08-1385 · Cited by 117
Skeletal muscle dysfunction in COPD: clinical and laboratory observations
Man, W. D., Kemp, P. R., Moxham, J., & Polkey, M. I. (2009) · Clinical Science · doi:10.1042/cs20080659 · Cited by 101
The Mitochondrial Phenotype of Peripheral Muscle in Chronic Obstructive Pulmonary Disease
Picard, M., Godin, R., Sinnreich, M., Baril, J., Bourbeau, J., Perrault, H., Taivassalo, T., & Burelle, Y. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1005oc · Cited by 95
Benefits of whole body vibration training in patients hospitalised for COPD exacerbations - a randomized clinical trial
Greulich, T., Nell, C., Koepke, J., Fechtel, J., Franke, M., Schmeck, B., Haid, D., Apelt, S., Filipovic, S., Kenn, K., et al. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-60 · Cited by 94
Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients
Rabinovich, R., & Vilaró, J. (2010) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328336438d · Cited by 93
Renin–angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease
Shrikrishna, D., Astin, R., Kemp, P. R., & Hopkinson, N. S. (2012) · Clinical Science · doi:10.1042/cs20120081 · Cited by 92
Main Pathogenic Mechanisms and Recent Advances in COPD Peripheral Skeletal Muscle Wasting
Henrot, P., Dupin, I., Schilfarth, P., Esteves, P., Blervaque, L., Zysman, M., Gouzi, F., Hayot, M., Pomiès, P., & Berger, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076454 · Cited by 85
“Remels and colleagues observed low levels of peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC1-α, the master regulator of mitochondrial biogenesis) and its downstream effector, mitochondrial transcription factor A (TFAM), in COPD quadriceps; these differences were further enhanced in cachectic…”
Background
Molecular regulation of skeletal muscle mass
Russell, A. P. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05265.x · Cited by 80
Skeletal muscle adiposity is associated with physical activity, exercise capacity and fibre shift in COPD
Maddocks, M. M., Shrikrishna, D., Vitoriano, S., Natanek, S. A., Tanner, R., Hart, N., Kemp, P. R., Moxham, J., Polkey, M. I., & Hopkinson, N. S. (2014) · European Respiratory Journal · doi:10.1183/09031936.00066414 · Cited by 81
Skeletal Muscle Mitochondrial Dysfunction during Chronic Obstructive Pulmonary Disease: Central Actor and Therapeutic Target
Meyer, A., Zoll, J., Charles, A. L., Charloux, A., de Blay, F., Diemunsch, P., Sibilia, J., Piquard, F., & Geny, B. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2012.069468 · Cited by 90
Skeletal Muscle Fiber Type in Hypoxia: Adaptation to High-Altitude Exposure and Under Conditions of Pathological Hypoxia
Chaillou, T. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01450 · Cited by 80
New Therapies for Chronic Obstructive Pulmonary Disease
Barnes, P. J. (2010) · Medical Principles and Practice · doi:10.1159/000316368 · Cited by 78
Future Treatments for Chronic Obstructive Pulmonary Disease and Its Comorbidities
Barnes, P. J. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200807-069th · Cited by 78
Eccentric Ergometer Training Promotes Locomotor Muscle Strength but Not Mitochondrial Adaptation in Patients with Severe Chronic Obstructive Pulmonary Disease
MacMillan, N. J., Kapchinsky, S., Goddard, Y., Gouspillou, G., Sena, R. D. S., Jagoe, R. T., Baril, J., Carver, T. E., Andersen, R. E., Richard, R., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00114 · Cited by 70
Comparative assessment of the quadriceps and the diaphragm in patients with COPD
Caron, M., Debigaré, R., Dekhuijzen, P. N. R., & Maltais, F. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00194.2009 · Cited by 69
Effects of exercise on mitochondrial DNA content in skeletal muscle of patients with COPD
Puente‐Maestu, L., Lázaro, A., Tejedor, A., Camaño, S., Fuentes, M., Cuervo, M., Navarro, B., & Agustí, A. G. N. (2010) · Thorax · doi:10.1136/thx.2010.153031 · Cited by 71
Peroxisome Proliferator-Activated Receptors as Novel Targets in Lung Disease *
Belvisi, M. G., & Hele, D. J. (2008) · CHEST Journal · doi:10.1378/chest.07-0019 · Cited by 66
Inactivation of glycogen synthase kinase-3β (GSK-3β) enhances skeletal muscle oxidative metabolism
Theeuwes, W. F., Gosker, H. R., LANGEN, R. C. J., Verhees, K. J. P., Pansters, N., Schols, A. M. W. J., & Remels, A. H. V. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.09.018 · Cited by 63
Self-citation
Systemic Inflammation and Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease: State of the Art and Novel Insights in Regulation of Muscle Plasticity
Remels, A. H. V., Gosker, H. R., van der Velden, J. L. J., LANGEN, R. C. J., & Schols, A. M. W. J. (2007) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2007.06.003 · Cited by 62
Self-citation
Sexually-dimorphic targeting of functionally-related genes in COPD
Glass, K., Quackenbush, J. F., Silverman, E. K., Celli, B. R., Rennard, S. I., Yuan, G., & DeMeo, D. L. (2014) · BMC Systems Biology · doi:10.1186/s12918-014-0118-y · Cited by 59
Exercise and muscle dysfunction in COPD: implications for pulmonary rehabilitation
Man, W. D., Kemp, P. R., Moxham, J., & Polkey, M. I. (2009) · Clinical Science · doi:10.1042/cs20080660 · Cited by 61
Fenofibrate, a PPARα agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy
Castillero, E., Nieto‐Bona, M. P., Fernández‐Galaz, C., Martı́n, A. I., López-Menduiña, M., Granado, M., Villanúa, M. Á., & López‐Calderón, A. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00590.2010 · Cited by 59
PPAR Gamma agonists regulate tobacco smoke-induced toll like receptor 4 expression in alveolar macrophages
Yin, Y., Hou, G., Li, E., Wang, Q., & Kang, J. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-28 · Cited by 57
Measuring and monitoring skeletal muscle function in COPD: current perspectives
Marklund, S., Bui, K.-L., & Nyberg, A. (2019) · International Journal of COPD · doi:10.2147/copd.s178948 · Cited by 55
Impact of nutritional status on body functioning in chronic obstructive pulmonary disease and how to intervene
Aniwidyaningsih, W., Varraso, R., Cano, N., & Pison, C. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3283023d37 · Cited by 53
Functional crosstalk of PGC-1 coactivators and inflammation in skeletal muscle pathophysiology
Eisele, P. S., & Handschin, C. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0406-4 · Cited by 54
Molecular Signalling towards Mitochondrial Breakdown Is Enhanced in Skeletal Muscle of Patients with Chronic Obstructive Pulmonary Disease (COPD)
Leermakers, P. A., Schols, A. M. W. J., Kneppers, A. E. M., Kelders, M. C. J. M., de Theije, C. C., Lainscak, M., & Gosker, H. R. (2018) · Scientific Reports · doi:10.1038/s41598-018-33471-2 · Cited by 53
Self-citation
Contribution of the Mitochondria to Locomotor Muscle Dysfunction in Patients with COPD
Taivassalo, T., & Hussain, S. N. A. (2016) · Chest · doi:10.1016/j.chest.2015.11.021 · Cited by 59
Altered mitochondrial regulation in quadriceps muscles of patients with COPD
Naimi, A. I., Bourbeau, J., Perrault, H., Baril, J., Wright‐Paradis, C., Rossi, A. M., Taivassalo, T., Sheel, A. W., Rabøl, R., Dela, F., et al. (2010) · Clinical Physiology and Functional Imaging · doi:10.1111/j.1475-097x.2010.00988.x · Cited by 51
Mitochondria in Chronic Obstructive Pulmonary Disease and Lung Cancer: Where are We Now?
Nam, H.-S., Izumchenko, E., Dasgupta, S., & Hoque, M. O. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0373 · Cited by 52
Ambient PM2.5 causes lung injuries and coupled energy metabolic disorder
Xia, N., Ji, X., Li, G., & Sang, N. (2018) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2018.12.028 · Cited by 51
Epigenetic Modifications and Therapy in Chronic Obstructive Pulmonary Disease (COPD): An Update Review
Zhang, L., Valizadeh, H., Alipourfard, I., Bidares, R., Maleki, L. A., & Ahmadi, M. (2020) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2020.1780576 · Cited by 51
Central Fat and Peripheral Muscle
van den Borst, B., Gosker, H. R., & Schols, A. M. W. J. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201208-1441oe · Cited by 53
Self-citation
Skeletal Muscle Dysfunction in Patients with Chronic Obstructive Pulmonary Disease
Kim, H. C., Lee, G. D., & Hwang, Y. S. (2010) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2010.68.3.125 · Cited by 50
Effects of the beta 2 agonist formoterol on atrophy signaling, autophagy, and muscle phenotype in respiratory and limb muscles of rats with cancer-induced cachexia
Salazar‐Degracia, A., Busquets, S., Argilés, J. M. A., Bargalló-Gispert, N., López-Soriano, F. J., & Barreiro, E. (2018) · Biochimie · doi:10.1016/j.biochi.2018.04.009 · Cited by 50
Resveratrol and metabolic health in COPD: A proof-of-concept randomized controlled trial
Beijers, R. J. H. C. G., Gosker, H. R., Sanders, K. J. C., de Theije, C. C., KELDERS, M. C. J. M., Clarke, G. A., Cryan, J. F., van den Borst, B., & Schols, A. M. W. J. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.01.002 · Cited by 48
Self-citation
TWEAK/Fn14 axis in respiratory diseases
Wang, M., Xie, Z., Xu, J., & Feng, Z. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.06.007 · Cited by 46
Failed Upregulation of TFAM Protein and Mitochondrial DNA in Oxidatively Deficient Fibers of Chronic Obstructive Pulmonary Disease Locomotor Muscle
Konokhova, Y., Spendiff, S., Jagoe, R. T., Aare, S., Kapchinsky, S., MacMillan, N. J., Rozakis, P., Picard, M., Aubertin-Leheudre, M., Pion, C. H., et al. (2016) · Skeletal Muscle · doi:10.1186/s13395-016-0083-9 · Cited by 46
Locomotor Muscles in COPD: The Rationale for Rehabilitative Exercise Training
Marillier, M., Bernard, A., Vergès, S., & Neder, J. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01590 · Cited by 47
Frontrunners in novel pharmacotherapy of COPD
Barnes, P. J. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.03.001 · Cited by 46
Regulation of skeletal muscle oxidative phenotype by classical NF-κB signalling
Remels, A. H. V., Gosker, H. R., Bakker, J. A., Guttridge, D. C., Schols, A. M. W. J., & LANGEN, R. C. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.018 · Cited by 46
Self-citation
Nutrition as a Metabolic Modulator in COPD
Schols, A. M. W. J. (2013) · CHEST Journal · doi:10.1378/chest.13-0326 · Cited by 46
Self-citation
Leukocyte Mitochondrial DNA Copy Number Is Associated with Chronic Obstructive Pulmonary Disease
Liu, S., Kuo, H., Tseng, C., Huang, H., Chen, Y., Tseng, C., & Lin, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138716 · Cited by 45
Current views in chronic obstructive pulmonary disease pathogenesis and management
Alfahad, A. J., Alzaydi, M. M., Aldossary, A. M., Alshehri, A. A., Almughem, F. A., Zaidan, N. M., & Tawfik, E. A. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.10.008 · Cited by 51
PGC-1α over-expression suppresses the skeletal muscle atrophy and myofiber-type composition during hindlimb unloading
Wang, J., Wang, F., Zhang, P., Liu, H., He, J., Zhang, C., Fan, M., & Chen, X. (2016) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1254531 · Cited by 43
Inactivation of glycogen synthase kinase 3β (GSK-3β) enhances mitochondrial biogenesis during myogenesis
Theeuwes, W. F., Gosker, H. R., LANGEN, R. C. J., Pansters, N., Schols, A. M. W. J., & Remels, A. H. V. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.06.002 · Cited by 43
Self-citation
Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease
Ghosh, A., Hobbs, B. D., Moll, M. R., Saferali, A., Boueiz, A. R., Yun, J. H., Sciurba, F. C., Barwick, L., LIMPER, A. H., Flaherty, K., et al. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202106-1404oc · Cited by 43
Hypoxia differentially regulates muscle oxidative fiber type and metabolism in a HIF-1α-dependent manner
Slot, I. G. M., Schols, A. M. W. J., Vosse, B. A. H., KELDERS, M. C. J. M., & Gosker, H. R. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.04.016 · Cited by 46
Self-citation
Time-Course of Muscle Mass Loss, Damage, and Proteolysis in Gastrocnemius following Unloading and Reloading: Implications in Chronic Diseases
Chacon‐Cabrera, A., Lund‐Palau, H., Gea, J., & Barreiro, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164951 · Cited by 42
Regulation of PGC-1α expression by a GSK-3β-TFEB signaling axis in skeletal muscle
Theeuwes, W. F., Gosker, H. R., Schols, A. M. W. J., LANGEN, R. C. J., & Remels, A. H. V. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118610 · Cited by 44
Self-citation
Resveratrol for patients with chronic obstructive pulmonary disease
Beijers, R. J. H. C. G., Gosker, H. R., & Schols, A. M. W. J. (2017) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000444 · Cited by 41
Self-citation
Hypoxia and muscle maintenance regulation
de Theije, C. C., Costes, F., LANGEN, R. C. J., Pison, C. M., & Gosker, H. R. (2011) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32834b6e79 · Cited by 41
Self-citation
Peroxisome proliferator-activated receptors: a therapeutic target in COPD?: Fig. 1—
Remels, A. H. V., Gosker, H. R., Schrauwen, P., LANGEN, R. C. J., & Schols, A. M. W. J. (2008) · European Respiratory Journal · doi:10.1183/09031936.00068207 · Cited by 41
Self-citation
Skeletal Muscle Mitochondrial Dysfunction in Chronic Obstructive Pulmonary Disease: Underlying Mechanisms and Physical Therapy Perspectives
Wang, Y., Li, P., Cao, Y., Liu, C., Wang, J., & Wu, W. (2022) · Aging and Disease · doi:10.14336/ad.2022.0603 · Cited by 41
The pathophysiology of cachexia in chronic obstructive pulmonary disease
Schols, A. M. W. J., & Gosker, H. R. (2009) · Current Opinion in Supportive and Palliative Care · doi:10.1097/spc.0b013e328331e91c · Cited by 38
Self-citation
Metabolic derangements in COPD muscle dysfunction
Puente‐Maestu, L., Lázaro, A., & Humanes, B. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00815.2012 · Cited by 42
Mitochondrial biology in airway pathogenesis and the role of NRF2
Cho, H., & Kleeberger, S. R. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01182-5 · Cited by 39
Regulation of peroxisome proliferator-activated receptor-α expression during lung inflammation
Becker, J., Delayre‐Orthez, C., Frossard, N., & Pons, F. (2007) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2007.08.001 · Cited by 35
Enhanced lipid—but not carbohydrate—supported mitochondrial respiration in skeletal muscle of PGC‐1α overexpressing mice
Hoeks, J., Arany, Z. P., Phielix, E., Moonen‐Kornips, E., Hesselink, M. K. C., & Schrauwen, P. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22812 · Cited by 36
Self-citation
A randomized clinical trial to assess the influence of a three months training program (Gym-based individualized vs. Calisthenics-based non-invidualized) in COPD-patients
Greulich, T., Kehr, K., Nell, C., Koepke, J., Haid, D., Koehler, U., Koehler, K., Filipovic, S., Kenn, K., Vogelmeier, C. F., et al. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-36 · Cited by 34
Pathways associated with reduced quadriceps oxidative fibres and endurance in COPD
Natanek, S. A., Gosker, H. R., Slot, I. G. M., Marsh, G. S., Hopkinson, N. S., Moxham, J., Kemp, P. R., Schols, A. M. W. J., & Polkey, M. I. (2012) · European Respiratory Journal · doi:10.1183/09031936.00098412 · Cited by 39
Self-citation
Expression and Methylation of Mitochondrial Transcription Factor A in Chronic Obstructive Pulmonary Disease Patients with Lung Cancer
Peng, H., Yang, M. H., Chen, Z.-Y., Chen, P., Guan, C., Xiang, X.-D., Cai, S., Chen, Y., & Fang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082739 · Cited by 34
Update on the Etiology, Assessment, and Management of COPD Cachexia: Considerations for the Clinician
Brandt, J. D., Beijers, R. J. H. C. G., Chiles, J. W., Maddocks, M. M., McDonald, M., Schols, A. M. W. J., & Nyberg, A. (2022) · International Journal of COPD · doi:10.2147/copd.s334228 · Cited by 36
Self-citation
The effect of acute and 7-days dietary nitrate on mechanical efficiency, exercise performance and cardiac biomarkers in patients with chronic obstructive pulmonary disease
Beijers, R. J. H. C. G., Huysmans, S., van de Bool, C., Kingma, B., Verdijk, L. B., van Loon, L. J. C., Meex, S. J. R., Gosker, H. R., & Schols, A. M. W. J. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.10.011 · Cited by 33
Self-citation
Phenotypic and metabolic features of mouse diaphragm and gastrocnemius muscles in chronic lung carcinogenesis: influence of underlying emphysema
Salazar‐Degracia, A., Blanco, D., Vilà-Ubach, M., de Biurrun, G., Ortíz-de-Solórzano, C., Montuenga, L. M., & Barreiro, E. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1003-9 · Cited by 34
Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease
Ghosh, A., Hobbs, B. D., Moll, M. R., Saferali, A., Boueiz, A. R., Yun, J. H., Sciurba, F. C., Barwick, L., LIMPER, A. H., Flaherty, K. R., et al. (2022) · UCL Discovery (University College London) · Cited by 32
The Relevance of Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease
Bui, K.-L., Nyberg, A., Rabinovich, R., Saey, D., & Maltais, F. (2019) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2019.02.013 · Cited by 36
Nutritional targets to enhance exercise performance in chronic obstructive pulmonary disease
van de Bool, C., STEINER, M. C., & Schols, A. M. W. J. (2012) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328358bdeb · Cited by 30
Self-citation
Skeletal muscle response to inflammation—Lessons for chronic obstructive pulmonary disease
Reid, W. D., Rurak, J., & Harris, R. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181b6ea1d · Cited by 30
Skeletal muscle mitophagy in chronic disease
Leermakers, P. A., & Gosker, H. R. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000319 · Cited by 31
Self-citation
Role of acute exacerbations in skeletal muscle impairment in COPD
Gosker, H. R., LANGEN, R. C. J., & Simons, S. O. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1843429 · Cited by 33
Self-citation
Chronic obstructive pulmonary disease and its comorbidities
Rabinovich, R., & MacNee, W. (2011) · British Journal of Hospital Medicine · doi:10.12968/hmed.2011.72.3.137 · Cited by 29
Prospects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease: a translational review
STEINER, M. C., Roubenoff, R., Tal‐Singer, R., & Polkey, M. I. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-201765 · Cited by 28
Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression
Remels, A. H. V., Gosker, H. R., LANGEN, R. C. J., Polkey, M. I., Sliwinski, P., Gáldiz, J. B., van den Borst, B., Pansters, N., & Schols, A. M. W. J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.11.001 · Cited by 28
Self-citation
Bronchial Asthma, Chronic Obstructive Pulmonary Disease and NF-κB
Charokopos, N., Apostolopoulos, N., Kalapodi, M., Leotsinidis, M., Karamanos, N. K., & Mouzaki, Α. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787549280 · Cited by 26
Utilization of non-invasive imaging tools for assessment of peripheral skeletal muscle size and composition in chronic lung disease: A systematic review
Rozenberg, D., Martelli, V., Vieira, L., Orchanian‐Cheff, A., Keshwani, N., Singer, L. G., & Mathur, S. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.08.007 · Cited by 27
Preserved muscle oxidative metabolic phenotype in newly diagnosed non‐small cell lung cancer cachexia
den Kamp, C. M. O., Gosker, H. R., Lagarde, S., Tan, D. Y. H., Snepvangers, F. J. M., Dingemans, A. C., LANGEN, R. C. J., & Schols, A. M. W. J. (2015) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12007 · Cited by 25
Self-citation
Bufei Jianpi Formula Improves Mitochondrial Function and Suppresses Mitophagy in Skeletal Muscle via the Adenosine Monophosphate-Activated Protein Kinase Pathway in Chronic Obstructive Pulmonary Disease
Mao, J., Li, Y., Feng, S., Liu, X., Tian, Y., Bian, Q., Li, J., Hu, Y., Zhang, L., Ji, H., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.587176 · Cited by 24
Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease
Cazzola, M., Ciaprini, C., Page, C. P., & Matera, M. G. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.10.1273 · Cited by 24
Immunologic Impact of Nutrient Depletion in Chronic Obstructive Pulmonary Disease
Herzog, R., & Cunningham-Rundles, S. (2011) · Current Drug Targets · doi:10.2174/138945011794751500 · Cited by 23
PGC-1α and PGC-1β increase CrT expression and creatine uptake in myotubes via ERRα
Brown, E. L., Snow, R. J., Wright, C. R., Cho, Y., Wallace, M. A., Kralli, A., & Russell, A. P. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.08.010 · Cited by 25
CT-derived muscle remodelling after bronchoscopic lung volume reduction in advanced emphysema
Sanders, K. J. C., Klooster, K., Vanfleteren, L. E. G. W., Slebos, D., & Schols, A. M. W. J. (2018) · Thorax · doi:10.1136/thoraxjnl-2018-211931 · Cited by 18
Self-citation
Mitochondrial HMG-Box Containing Proteins: From Biochemical Properties to the Roles in Human Diseases
Vozáriková, V., Kunová, N., Bauer, J., Frankovský, J., Kotrasová, V., Procházková, K., Džugasová, V., Kutějová, E., Pevala, V., Nosek, J., et al. (2020) · Biomolecules · doi:10.3390/biom10081193 · Cited by 19
Chronic obstructive pulmonary disease patient journey: hospitalizations as window of opportunity for extra-pulmonary intervention
Lainščak, M., Gosker, H., & Schols, A. (2013) · Current opinion in clinical nutrition and metabolic care · doi:10.1097/mco.0b013e328360285d · Cited by 15
Self-citation
Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities
Sinden, N., & Stockley, R. A. (2010) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310370631 · Cited by 18
Can muscle protein metabolism be specifically targeted by exercise training in COPD?
Simoes, D. C. M., & Vogiatzis, I. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.02.67 · Cited by 17

Authors: Remels, A. H., Schrauwen, P., Broekhuizen, R., Willems, J., Kersten, S., Gosker, H. R., & Schols, A. M.
Affiliations: Maastricht University (NL)
ORCID: Schrauwen, P.
Kersten, S.
Gosker, H. R.
Schols, A. M.
Venue: European Respiratory Journal
Publisher: European Respiratory Society (ERS)
Published: 2007-04-25
Volume: 30
Issue: 2
Pages: 245-252
ISSN: 0903-1936 (ISSN-L)
1399-3003
DOI: 10.1183/09031936.00144106
OpenAlex: W2137507155
Cited by: 168
References: 35
Citations by year: 2026: 2 · 2025: 8 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 13 · 2019: 9 · 2018: 8 · 2017: 12 · 2016: 12 · 2015: 6 · 2014: 12 · 2013: 14 · 2012: 10
FWCI: 4.88
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: European Respiratory Journal (publishedVersion)
PubMed (publishedVersion)
Research Publications (Maastricht University) (publishedVersion, other-oa)
Socio-Environmental Systems Modeling (submittedVersion)
Research Publications (Maastricht University) (submittedVersion, other-oa)
Data Archiving and Networked Services (DANS) (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
Keywords: chronic obstructive pulmonary disease, skeletal muscle, cachexia, PPARγ, PPARδ, PPARα, PGC-1α, TFAM, mitochondrial biogenesis, muscle weakness, systemic inflammation, gene expression
MeSH terms: Aged, Analysis of Variance, Body Composition, DNA-Binding Proteins, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Middle Aged, Phenotype, Respiratory Function Tests, Transcription Factors, Tumor Necrosis Factor-alpha, Blotting, Western, Case-Control Studies, Muscle, Skeletal, Reverse Transcriptase Polymerase Chain Reaction, Mitochondrial Proteins, Pulmonary Disease, Chronic Obstructive, Peroxisome Proliferator-Activated Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks